Top Markets
Coin of the day
Stella Pharma Corporation Stella Pharma Corporation

Stella Pharma Corporation

4888
Rank in Stocks #22897
Stella Pharma Corporation is a pharmaceutical company that handles the complete... Stella Pharma Corporation is a pharmaceutical company that handles the complete process of drug development, from research and manufacturing to distribution. A core area of its specialization is in therapeutic agents for boron neutron capture therapy (BNCT). Their product lineup includes SPM-011, a boron-containing drug designed for BNCT, which is utilized in the treatment of head and neck cancer, recurrent malignant glioma, meningioma, malignant melanoma, and angiosarcoma. Founded in 2007, Stella Pharma Corporation maintains its headquarters in Osaka, Japan.
Share Price
$2.26
Last synced: 2026-08-21
Market Cap
$81.55M
Change (1 day)
-0.86%
Change (1 year)
-18.45%
Country
JP
Trade Stella Pharma Corporation (4888)

Category

Operating Margin for Stella Pharma Corporation (4888)
Operating Margin as of 2026 TTM: 0.00%
According to Stella Pharma Corporation latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Stella Pharma Corporation from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.59% -
US
28.81% -
NL
-149.01% -
US
25.72% -
AU
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.